J Biol Chem, Vol. 274, Issue 42, 30258-30265, October 15, 1999
Neuronal Ca2+ Sensor 1
CHARACTERIZATION OF THE MYRISTOYLATED PROTEIN, ITS CELLULAR
EFFECTS IN PERMEABILIZED ADRENAL CHROMAFFIN CELLS,
Ca2+-INDEPENDENT MEMBRANE ASSOCIATION, AND INTERACTION WITH
BINDING PROTEINS, SUGGESTING A ROLE IN RAPID Ca2+ SIGNAL
TRANSDUCTION*
Brian W.
McFerran,
Jamie L.
Weiss, and
Robert D.
Burgoyne
From The Physiological Laboratory, University of Liverpool, Crown
Street, Liverpool L69 3BX, United Kingdom
 |
ABSTRACT |
Overexpression of frequenin and its orthologue
neuronal Ca2+ sensor 1 (NCS-1) has been shown to
increase evoked exocytosis in neurons and neuroendocrine cells. The
site of action of NCS-1 and its biochemical targets that affect
exocytosis are unknown. To allow further investigation of NCS-1
function, we have demonstrated that NCS-1 is a substrate for
N-myristoyltransferase and generated recombinant
myristoylated NCS-1. The bacterially expressed NCS-1 shows
Ca2+-induced conformational changes. The possibility that
NCS-1 directly interacts with the exocytotic machinery to enhance
exocytosis was tested using digitonin-permeabilized chromaffin cells.
Exogenous NCS-1 was retained in permeabilized cells but had no effect
on Ca2+-dependent release of catecholamine. In
addition, exogenous NCS-1 did not regulate cyclic nucleotide levels in
this system. These data suggest that the effects of NCS-1 seen in
intact cells are likely to be due to an action on the early steps of
stimulus-secretion coupling or on Ca2+ homeostasis.
Myristoylated NCS-1 bound to membranes in the absence of
Ca2+ and endogenous NCS-1 was tightly membrane-associated.
Using biotinylated NCS-1, a series of specific binding proteins were
detected in cytosol, chromaffin granule membrane, and microsome
fractions of adrenal medulla. These included proteins distinct from
those detected by biotinylated calmodulin, demonstrating the presence of multiple specific Ca2+-independent and
Ca2+-dependent binding proteins as putative
targets for NCS-1 action. A model for NCS-1 function, from these data,
indicates a constitutive membrane association independent of
Ca2+. This differs from the Ca2+ myristoyl
switch model for the closely related recoverin and suggests a possible
action in rapid Ca2+ signal transduction in response to
local Ca2+ signals.
 |
INTRODUCTION |
Among the many EF-hand-containing Ca2+-binding
proteins is a family known as the recoverin/neurocalcin or neuronal
calcium sensor family (1). These small Ca2+-binding
proteins include members expressed only in photoreceptor cells such as
recoverin (2), the best characterized of this family (3). Recoverin has
a well defined function in the control of rhodopsin phosphorylation due
to direct inhibition of rhodopsin kinase (3, 4). Other members such as
VILIP (6) neurocalcin (7), hippocalcin (8), frequenin (9), and neuronal
Ca2+ sensor 1 (NCS-1) (10) are highly expressed in neurons
and were originally all believed to be neuron-specific implying a key
role in Ca2+-regulated events in the nervous system. The
cellular function of many of the neuronal proteins of this family
remains a mystery, but, in contrast, some insight has been gained into
the role of frequenin/NCS-1 in the regulation of presynaptic function.
Frequenin is a Drosophila protein that has been demonstrated
in molecular genetic and other studies to regulate synaptic
neurotransmission. Overexpression of frequenin in
Drosophila, in the V7 mutant (9), was found to facilitate
evoked neurotransmission at the neuromuscular junction, and a direct
stimulation of both spontaneous and evoked neurotransmission was found
following injection of Xenopus frequenin into
Xenopus spinal neurons (11). NCS-1, first identified in chickens (10) and later in rodents (12, 13) and Caenorhabditis elegans (13), appears to be the frequenin orthologue expressed in
those species. Recently, it has been shown that NCS-1 is not expressed
solely in neurons, since it was detected in glial cells in the central
nervous system (12). In addition, it is present in adrenal chromaffin
cells and PC12 neuroendocrine cells, where its overexpression also
results in an increase in Ca2+-regulated exocytosis but
from dense-core granules (14), analogous to the effect reported for
frequenin in Drosophila for synaptic vesicle exocytosis (9).
It is clear, therefore, that frequenin/NCS-1 has an important
regulatory role in the steps leading to
Ca2+-dependent exocytosis of synaptic vesicles
and dense core granules in neurons and neuroendocrine cells. The step
in the exocytotic sequence at which frequenin/NCS-1 acts is, however,
not known.
The biochemical processes on which NCS-1 might act in vivo
are also unclear. From in vitro experiments, frequenin has
been shown to activate membrane-bound guanylate cyclase, but only at low Ca2+ concentration, in rod outer segments (9) and NCS-1
to inhibit rhodopsin kinase (13). These in vitro effects on
photoreceptor proteins may not be relevant to the function of
frequenin/NCS-1 in neurons and neuroendocrine cells. In addition, NCS-1
has been shown to activate various calmodulin targets including cyclic nucleotide phosphodiesterase, calcineurin, and nitric-oxide synthase (15). NCS-1 has also been implicated as a direct or indirect (via cGMP)
activator of Ca2+-dependent K+
channels (9, 15, 16) and also Na2+/Ca2+
exchange (17). Despite these interactions, the molecular targets for
frequenin/NCS-1 action in vivo are not known for certain, and thus the mechanism by which evoked exocytosis is increased remains
to be elucidated.
From analysis of its biochemical properties (18, 19) and structure (3),
recoverin has been described as a calcium-myristoyl switch, and this
was initially assumed to typify the behavior of all members of this
family of proteins. Ca2+ binding to two of the four
EF-hand-like domains of recoverin leads to the exposure of an
N-terminal myristoyl group (3) believed to allow membrane attachment
(19). The movement of the myristoyl group also exposes a hydrophobic
pocket that may then interact with target proteins (3). All other
members of this family possess consensus myristoylation motifs (20)
and, in the case of recoverin (19), neurocalcin (21, 22), and hippocalcin (23), only the myristoylated and not the nonmyristoylated protein shows Ca2+-dependent binding to
membranes consistent with the calcium-myristoyl switch model. In
contrast, another family member, the guanyl cyclase-activating protein
2, shows the distinct property of only binding to membranes and
activating its target protein at low Ca2+ concentration and
dissociates from membranes at micromolar Ca2+ (24).
Frequenin and NCS-1 possess a putative N-myristoylation motif (10-12), but their myristoylation and Ca2+
dependence of membrane binding have not been examined for either native
or recombinant protein.
The aims of this study were to examine whether NCS-1 is a substrate for
myristoyltransferase by bacterial co-expression with the yeast enzyme
(25), to characterize myristoylated NCS-1, and to use the recombinant
protein to investigate cellular functions of NCS-1. The results show
that NCS-1 does indeed act as a substrate for
N-myristoyltransferase, and the recombinant protein shows Ca2+-dependent conformational changes but
Ca2+-independent interaction with membranes, and thus its
behavior differs from recoverin. In addition, we have shown that NCS-1 does not appear to act directly on the exocytotic machinery in adrenal
chromaffin cells, nor does it modulate cyclic nucleotide levels in
permeabilized cells. Endogenous NCS-1 is tightly associated with
cellular membranes in a Ca2+-independent manner, and we
have detected multiple putative Ca2+-dependent
and Ca2+-independent membrane target proteins using
recombinant NCS-1.
 |
MATERIALS AND METHODS |
Plasmid Production--
Total RNA was extracted from whole brain
of Wistar rats using an RNeasy isolation kit (Qiagen, Surrey, UK) and
cDNA synthesized with a reverse transcription system. cDNA
encoding NCS-1 was amplified in polymerase chain reactions using
Pfu polymerase (Stratagene, Cambridge, UK), according to the
supplier's protocol, and an Omne-E dryblock thermocycler (Hybaid,
Middlesex, UK). The sense and antisense primers used were
5'-CATCATATGGGGAAATCCAACAGCAAGTTGA-3' and
5'-CATGGATCCCTATACCAGCCCGTCGTAGAGG-3', respectively. These were based on the nucleotide sequence of rat NCS-1 (Ref. 13; GenBankTM accession no. L27421) and
incorporated NdeI and BamHI restriction sites
(underlined) to facilitate subcloning of the product into the pET-5a
expression vector (Promega, Southampton, UK). The nucleotide sequence
was established by automated sequencing.
Expression and Purification of Recombinant NCS-1--
BL21 (DE3)
cells (Promega) were transformed with pBB131 (25), a plasmid encoding
N-myristoyltransferase (NMT; myristoyltransferase-CoA; protein N-myristoyltransferase (EC 2.3.1.97)) and
subsequently with the above pET-5a/NCS-1 construct. Expression of both
recombinant NCS-1 and NMT was induced with 1 mM
isopropyl-1-thio-
-D-galactopyranoside at 37 °C for
4 h in the presence of 5 µg/ml myristate. The expression of
myristoylated NCS-1 was confirmed by means of fluorography following
induction of expression in the presence of 25 µCi/ml [3H]myristate (Amersham Pharmacia Biotech,
Buckinghamshire, UK). For production of labeled purified protein, a
500-ml culture was grown in the presence of 1.5 µCi/ml
[3H]myristate. Cells were harvested by centrifugation and
resuspended in buffer A (50 mM HEPES (pH 7.5), 100 mM KCl, 1 mM dithiothreitol, and 1 mM MgCl2) supplemented with protease inhibitors
(1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin,
and 1 mM pepstatin A) and stored at
80 °C until required.
Myristoylated NCS-1 was purified using methods adapted from those of
Zozulya et al. (26) for recoverin and neurocalcin. Upon
thawing, cells were added to 1 volume of buffer A supplemented with 0.2 mM EGTA, incubated with 1 mg/ml lysozyme for 30 min, ultrasonicated, and incubated with 2 µg/ml DNase for 15 min, and finally cell debris was removed by centrifugation at 100,000 × g for 1 h. The cleared lysate was supplemented with 1 mM CaCl2 and applied to a phenyl-Sepharose
(Amersham Pharmacia Biotech, Uppsala, Sweden) column. The column was
washed, and NCS-1 was eluted with buffer A containing 5 mM
EGTA. For further purification, pooled eluted fractions containing
NCS-1 were diluted with 3 volumes of water and applied to a Q-Sepharose
(Amersham Pharmacia Biotech) column equilibrated with buffer B (20 mM Tris-HCl, (pH 8.0), 1 mM dithiothreitol, and
50 mM EGTA), and NCS-1 was eluted with a 0-600
mM KCl gradient in a single peak. All chromatography was performed at room temperature (22-25 °C) using an Amersham
Pharmacia Biotech FPLC system. Peak fractions containing recombinant
proteins were analyzed by SDS-polyacrylamide gel electrophoresis, and
the pooled fractions were stored at
80 °C until required. Analysis by HPLC used reverse phase chromatography with elution by a 0-50% acetonitrile gradient.
SDS-Polyacrylamide Gel Electrophoresis--
Samples for
electrophoresis were routinely dissolved in sample buffer (125 mM HEPES (pH 6.8), 1.25% SDS (w/v), 2 mM EDTA, 10% sucrose (w/v), 1%
-mercaptoethanol, 10% glycerol (v/v), and 0.001% bromphenol blue), boiled, and separated on a 10 or 15% SDS-polyacrylamide gel. For experiments investigating calcium binding
to NCS-1, EDTA was omitted and replaced with either 5 mM
EGTA or 5 mM CaCl2. For detection of
[3H]myristate incorporation, gels were impregnated with
Amplify (Amersham Pharmacia Biotech), dried, and exposed on x-ray film overnight at
70 °C.
Tryptophan Fluorescence Emission Spectra--
Purified
recombinant NCS-1 (1 µM) in 20 mM HEPES (pH
7.4), 139 mM NaCl, 2 mM ATP, 5 mM
nitrilotriacetic acid, and 5 mM EGTA was excited at room
temperature at a wavelength of 280 nm, and the emission spectra from
290 to 410 nm were detected using a Perkin-Elmer LS-5 luminescence
spectrometer. The free Ca2+ concentration was increased by
incremental additions of CaCl2, and the subsequent spectra
were similarly recorded.
Preparation of Membranes from Rat Brain--
Whole brains of
Wistar rats were homogenized in HEPES (pH 7.2), 140 mM
sucrose, 70 mM potassium acetate, 1 mM
dithiothreitol, and 230 µM phenylmethylsulfonyl fluoride
and centrifuged at 1600 × g for 10 min at 4 °C. The
supernatant was removed and centrifuged at 100,000 × g
for 60 min at 4 °C, and the subsequent pellet was resuspended in 125 mM Na2CO3 (pH 11.5). After
incubation at 4 °C for 30 min, membranes were obtained by
centrifugation at 100,000 × g for 60 min at 4 °C;
resuspended in 20 mM HEPES (pH 7.4), 100 mM
NaCl, and 2 mM EDTA; and stored at 4 °C until required.
Determination of NCS-1 Association with Membranes--
Membranes
were washed twice by centrifugation at 13000 × g for
10 min at room temperature, with 20 mM HEPES (pH 7.4), 139 mM NaCl, 2 mM ATP, 5 mM
nitrilotriacetic acid, and 5 mM EGTA and finally
resuspended in the same buffer with added MgCl2 and
CaCl2 to give a calculated free Mg2+
concentration of 2 mM and free Ca2+
concentration of 0 or 10 µM. After incubation at room
temperature for 30 min with 3H-labeled NCS-1 in a total
volume of 500 µl, the membranes were washed twice in the appropriate
calcium buffer, and duplicate aliquots were subjected to scintillation
counting. Background values for NCS-1 bound in the absence of brain
membrane were subtracted.
Determination of Endogenous NCS-1 Leakage from Permeabilized
Chromaffin Cells--
Bovine chromaffin cell cultures were prepared
and maintained as described previously (27). Cells were permeabilized
in 300 µl/well permeabilization buffer (20 mM PIPES (pH
6.5), 139 mM potassium glutamate, 5 mM EGTA, 2 mM ATP, and 2 mM MgCl2) containing 20 µM digitonin (Novabiochem, Nottingham, UK). After the
indicated times, the supernatants were centrifuged at 13,000 × g for 3 min to remove cell debris, and then both
supernatants and cells were precipitated with an equal volume of
methanol at
20 °C to concentrate protein samples before
solubilization in 300 µl of SDS dissociation buffer and boiling.
Samples were separated on a 15% SDS-polyacrylamide gel and analyzed by
immunoblotting as above.
Assay of Catecholamine Secretion from Permeabilized Chromaffin
Cells--
For secretion assays, the cells were permeabilized as above
for 10 min (step 1). Subsequent incubations were carried out in 20 mM HEPES (pH 7.4), 139 mM NaCl, 2 mM ATP, 5 mM nitrilotriacetic acid, and 5 mM EGTA in the presence of various amounts of
CaCl2 and MgCl2 to give the desired free
Ca2+ concentration and a calculated free Mg2+
concentration of 2 mM. The cells were then incubated for 15 min in the presence or absence of recombinant NCS-1 in the absence of
Ca2+ (step 2). Cells were then challenged in step 3 with
buffer containing no Ca2+ or up to 10 µM free
Ca2+, again in the presence or absence of recombinant
NCS-1, and catecholamine released over a 40-min period was determined
by means of a fluorometric assay (28). All experiments were performed
at room temperature.
Assay of cAMP and cGMP Production in Permeabilized Chromaffin
Cells--
Cells were permeabilized and treated as above. For assay of
cAMP, the incubation medium was removed after step 3, mixed with an
equal volume of 10 mM Tris-HCl (pH 7.5) and 8 mM EDTA, boiled for 2 min, sonicated for 15 s, and
centrifuged at 13,000 × g for 3 min. Levels of cAMP in
the subsequent supernatants were determined using the appropriate
enzyme immunoassay kit (Amersham Pharmacia Biotech) according to the
manufacturer's instructions. For the assay of cGMP,
volume
of lysis buffer (5% dodecyltrimethylammonium bromide in 0.05 M sodium acetate, pH 5.8) was added to the wells at the end
of the incubation in step 3, and samples were taken for assay of cGMP
after the acetylation of samples using an enzyme immunoassay kit
(Amersham Pharmacia Biotech).
Characterization of Binding of Biotinylated Proteins to Adrenal
Medulla Subcellular Fractions--
Cytosol, chromaffin granule
membrane, and microsome fractions were prepared from bovine adrenal
medulla by standard techniques (29). For biotinylation of recombinant
NCS-1, ADP-ribosylation factor 1 (ARF1), or purified bovine brain
calmodulin (Sigma), the proteins (200 µg/ml) were mixed with
6-(biotinamidocaproylamindo) N-hydroxysuccinimide ester
(Sigma) from a stock solution in Me2SO to give a 100-fold
molar excess of biotinylating reagent. Incubation was performed at room
temperature for 2 h and stopped by the addition of a final
concentration of 100 mM glycine. To remove excess biotin, biotinylated proteins were dialyzed against 20 mM HEPES,
139 mM NaCl, 2 mM ATP, 5 mM EGTA, 5 mM nitrilotriacetic acid, pH 7.4. The concentration of the
biotinylated proteins was determined by taking
A280 and converting to mg/ml based on the
predicted molar extinction coefficient. Biotinylated probes were stored at
20 °C until use. Proteins separated on SDS gels were blotted onto nitrocellulose membranes for analysis. Membranes were incubated in
blocking solution (the above buffer plus 5% milk, 5% bovine serum
albumin, 5% fetal calf serum, and 0.5% Tween 20) at room temperature
for 2 h with three changes and then incubated overnight at 4 °C
with biotinylated probes at 3.6-8 µg/ml in blocking solution (with
the addition of MgCl2 and CaCl2 to obtain the
appropriate free Ca2+ concentration and 2 mM
free Mg2+). Membranes were washed four times in buffer plus
the appropriate free Ca2+ concentration and 0.5% Tween 20 and incubated with Streptavidin-horseradish peroxidase at 1:400 in
blocking solution for 30 min. The membranes were washed four times as
above, and bound biotinylated fragments were detected using enhanced
chemiluminescence (Amersham Pharmacia Biotech). In other experiments,
binding of biotinylated proteins to bovine brain calcineurin (Sigma)
was assayed using a similar protocol.
 |
RESULTS |
Expression of Myristoylated NCS-1--
NCS-1 has a potential
N-terminal myristoylation site (10-12), related to the consensus motif
recognized by N-myristoyltransferase (20). To determine
whether NCS-1 can be a substrate for N-myristoyltransferase, NCS-1 was co-expressed in bacteria with the yeast enzyme, and [3H]myristic acid was added to the growth medium to allow
detection of myristic acid incorporation. Bacterial cultures expressing the enzyme alone revealed no labeled polypeptides following an overnight exposure of the fluorography. In contrast, when both plasmids
for N-myristoyltransferase and for NCS-1 were present, an
intensively labeled polypeptide of the expected size for NCS-1 was
detected by fluorography after induction of protein expression with
isopropyl-1-thio-
-D-galactopyranoside (Fig.
1A), and labeled NCS-1 could
be purified (see below), suggesting that NCS-1 is indeed an effective
substrate for the NMT enzyme, which is known to show unique specificity
for myristate.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Myristoylation of bacterially expressed NCS-1
and its purification. A, fluorography of
Escherichia coli extracts grown in the presence of
[3H]myristic acid. The extracts were prepared from
cultures with or without induction by
isopropyl-1-thio- -D-galactopyranoside (IPTG)
from bacteria containing plasmid encoding NMT alone or both plasmids
for NMT and NCS-1 as indicated. B, elution of expressed
NCS-1 from phenyl-Sepharose by 5 mM EGTA and analysis of
fractions by SDS-PAGE and Coomassie Blue staining. C,
characterization of NCS-1, purified on phenyl-Sepharose, by reverse
phase HPLC. The inset shows the presence of NCS-1 in the
loaded material (L) and in the first (1) and
second (2) peaks from the HPLC.
|
|
For bulk expression of myristoylated NCS-1 protein, expression was
induced in bacterial cultures grown with the addition of 5 µg/ml
myristic acid to the medium. The NCS-1 was expressed in high levels as
a soluble protein, and after bacterial cell lysis, the NCS-1 was
purified by Ca2+-dependent chromatography on
phenyl-Sepharose. This single step purification gave a substantial
purification of NCS-1 from the bacterial lysate (Fig. 1B).
In some cases, further purification was carried out by ion exchange
chromatography, but this was not routinely required and did not
markedly improve the purity of the NCS-1. On both phenyl-Sepharose and
ion exchange chromatography, NCS-1 resolved as a single but asymmetric
peak with a long tail. Since it was possible that not all of the
protein would be myristoylated, further analysis was carried out to
determine the relative amounts of myristoylated and nonmyristoylated
protein in the pool of purified protein. Analysis of purified NCS-1 by
reverse-phase HPLC revealed two discrete peaks both of which contained
NCS-1 when analyzed by SDS-PAGE (Fig. 1C). The first
corresponded to the position of [3H]myristate-labeled
NCS-1 in other experiments, so the myristoylated pool of NCS-1 from
Fig. 1C amounted to 58% of the total NCS-1.
Ca2+ Binding Properties of Recombinant NCS-1--
To
establish the functional nature of the bacterially expressed
myristoylated NCS-1, its ability to bind Ca2+, leading to
Ca2+-dependent conformational change, was
assessed. First, the effect of Ca2+ on migration of NCS-1
on SDS-PAGE was examined. As shown for other related
Ca2+-binding proteins such as Drosophila
frequenin (9), NCS-1 underwent a conformational change in the presence
of Ca2+ that resulted in faster migration on SDS-PAGE (Fig.
2A). In addition, conformational change could be demonstrated due to increasing Ca2+ concentration from the monitoring of tryptophan
fluorescence emission. NCS-1 possesses two tryptophans at positions 30 and 103 (10-12), and previous work using nonmyristoylated bacterially expressed NCS-1 showed an increase in peak emission due to tryptophan fluorescence when Ca2+ was added (30). With the
myristoylated NCS-1, a similar increase in peak emission at about 340 nm (Fig. 2B) was detected at low Ca2+
concentrations (<1 µM), but a second effect, not
previously observed, was also seen at higher Ca2+ in which
the peak emission declined (Fig. 2C) to the original levels
and concomitant peak broadening occurred toward higher wavelengths
(Fig. 2B). These data suggest two distinct
Ca2+-dependent conformational changes in NCS-1
consistent with the existence of at least two distinct
Ca2+-binding sites. The Ca2+ dependence of the
two conformational changes differed by almost 1000-fold.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 2.
Ca2+-dependent
conformational changes in NCS-1 detected by SDS-PAGE and tryptophan
fluorescence. A, NCS-1 was analyzed by SDS-PAGE in the
presence of 5 mM EGTA or 5 mM
CaCl2. The NCS-1 was run at two different protein loadings
(2.5 µg on left, 5 µg on right), and in each
case the protein migrated faster in the presence of CaCl2.
MW, molecular weight markers. B, fluorescence
emission spectra of NCS-1 in the absence of Ca2+ (control)
or in the presence of 0.3 µM or 1 mM free
Ca2+. NCS-1 at 1 µM was excited at 280 nM. C, the change in tryptophan fluorescence
over a range of Ca2+ concentrations. The concentration of
free Ca2+ was increased by the sequential addition of
CaCl2, and the emission spectrum was measured after each
addition. The data shown are the increase in peak emission as a
percentage of the control trace and are shown as mean ± S.E.
(n = 3).
|
|
Ca2+-independent Binding of NCS-1 to Brain
Membranes--
Closely related Ca2+-binding proteins such
as recoverin (19), hippocalcin (23), and neurocalcin (21, 22) bind to
membranes when myristoylated but not in the nonmyristoylated state.
This binding is strictly Ca2+-dependent, and
the endogenous proteins can be stripped from membranes by
Ca2+ chelators. We therefore determined whether the
recombinant NCS-1 protein would show
Ca2+-dependent interaction with cellular
membranes in the presence of physiological (millimolar)
Mg2+ concentration. It should be noted that we previously
observed that endogenous NCS-1 can be tightly associated with adrenal
medulla membranes in the presence of Ca2+ chelator (14),
and even after washing with chelator and subsequently with carbonate
buffer at pH 11.5, endogenous membrane-associated NCS-1 was still
detectable (Fig. 3A). To
specifically determine binding of myristoylated NCS-1, the recombinant
protein was prepared as a [3H]myristate-labeled protein
(Fig. 3B). Incubation of carbonate-washed rat brain
membranes with recombinant [3H]NCS-1 resulted in further
binding of myristoylated NCS-1 in a Ca2+-independent manner
to the membranes (Fig. 3C). No differences in the extent of
binding were seen over the Ca2+ range of 0-100
µM. These data show that NCS-1 has a pattern of membrane
interaction distinct from closely related family members and that does
not fit the recoverin Ca2+/myristoyl switch model.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Ca2+-dependent
binding of NCS-1 to carbonate-washed rat brain membranes.
A, immunoblot with anti-NCS-1 of rat brain membranes
(memb) and following washing with 2 mM EGTA and
then subsequently with carbonate buffer at pH 11.5. B,
fluorography of purified [3H]myristate-labeled NCS-1
showing a single labeled band. C, membranes were prepared
from a rat brain homogenate and carbonate-washed to remove extrinsic
proteins. The membranes were incubated with [3H]NCS-1 at
various concentrations as indicated in the presence of calculated 2 mM free Mg2+ at 0 or 10 µM free
Ca2+. Bound NCS-1 was detected after washing the membranes
by scintillation counting. The data were calculated as cpm bound/mg of
membrane protein and are shown as mean ± S.E. (n = 4-8).
|
|
NCS-1 Does Not Directly Stimulate
Ca2+-dependent Exocytosis in Permeabilized
Chromaffin Cells--
In order to examine whether NCS-1 exerts its
stimulatory effects on Ca2+-regulated exocytosis directly
via interaction with the exocytotic machinery, we used
digitonin-permeabilized adrenal chromaffin cells. This is a well
characterized model system for the analysis of dense core granule
exocytosis, which allows exchange of soluble proteins within the cells
and demonstration of stimulatory effects of various added soluble
proteins (31, 32). The possibility that bacterially expressed NCS-1
might stimulate exocytosis after the addition to permeabilized cells
was examined. Initially we determined the cellular content of
endogenous NCS-1 following permeabilization. Within 15 min of digitonin
permeabilization, about 50% of NCS-1 was lost from the cells, but the
remainder was retained in the cells following a longer permeabilization time even in the absence of Ca2+ (Fig.
4A). When permeabilized cells
were incubated with 100 µg/ml (5 µM) bacterially
expressed myristoylated NCS-1, increased levels of NCS-1 were detected,
after prolonged washing of the cells in either 0 or 10 µM
Ca2+, due to retention of the added protein with an
approximate 3-fold increase compared with control cells at the end of
the incubations (Fig. 4B). For analysis of exocytosis, the
cells were permeabilized, preincubated for 15 min with or without
NCS-1, and stimulated with 0 or 10 µM free
Ca2+. In some experiments, NCS-1 was also included in the
stimulation step. The concentration of NCS-1 was based on maximally
effective concentrations of the nonmyristoylated protein in published
in vitro assays (16). Under no conditions did exogenously
added NCS-1 stimulate exocytotic release of catecholamine. No effect was seen on the Ca2+-dependence of exocytosis based on a
lack of effect at maximal (10 µM Ca2+) or a
low (1.2 µM) Ca2+ concentration (Fig.
4C). Similar results were obtained with two separate batches
of myristoylated NCS-1 and also with nonmyristoylated His6-tagged protein. These findings argue against a direct
effect of NCS-1 on the exocytotic machinery and suggest that its
effects in intact cells may be due to regulation of signal transduction pathways.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Exchange of NCS-1 in permeabilized adrenal
chromaffin cells and effect on Ca2+-dependent
exocytosis. A, chromaffin cells were permeabilized with
digitonin for 5, 15, or 30 min, and the amount of NCS-1 remaining in
the cells or leaked into the supernatant was analyzed by SDS-PAGE and
immunoblotting with anti-NCS-1. B, chromaffin cells were
permeabilized for 10 min, incubated in 0 µM
Ca2+ with or without 5 µM NCS-1 for 15 min,
and then further incubated with 0 or 10 µM
Ca2+ for 40 min as indicated. After an additional wash,
NCS-1 associated with the cells was analyzed by SDS-PAGE and
immunoblotting. C, lack of effect of exogenous NCS-1 on
Ca2+-dependent exocytosis in permeabilized
chromaffin cells. Chromaffin cells were permeabilized for 10 min,
incubated without (control) or with 5 µM NCS-1 in 0 µM Ca2+ for 15 min and then challenged with
1, 1.2, or 10 µM free Ca2+ as indicated.
Catecholamine released over a 40-min stimulation period was assayed and
expressed as a percentage of total cellular catecholamine, and the data
are shown as mean ± S.E. (n = 4).
|
|
NCS-1 Does Not Modify Cyclic Nucleotide Levels in Permeabilized
Chromaffin Cells--
Exocytosis induced by Ca2+ can be
regulated by cyclic nucleotides, and NCS-1 has been suggested to
regulate cyclic nucleotide levels due to a stimulation of cyclic
nucleotide phosphodiesterase (16) and frequenin to activate
membrane-bound guanylate cyclase (9). We investigated, therefore,
whether exogenous NCS-1 would affect cyclic nucleotide levels in
permeabilized chromaffin cells. Neither NCS-1 nor Ca2+
alone had any effect on cGMP levels when assayed in the presence of the
phosphodiesterase inhibitor IBMX, ruling out any activation of
guanylate cyclase (Fig. 5A).
The effect of NCS-1 on cAMP levels was assayed in the absence of IBMX
to allow examination of effects either on phosphodiesterase or on
adenylate cyclase activity. In the absence of IBMX (Fig. 5B)
or in its presence (not shown), cAMP levels were elevated due to
Ca2+, but no effect of NCS-1 on cAMP levels in the absence
or presence of Ca2+ was seen.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of Ca2+ and NCS-1 on cAMP
and cGMP generation in permeabilized adrenal chromaffin cells.
A, chromaffin cells were permeabilized with digitonin for 10 min, incubated without (control) or with 5 µM NCS-1 in
the presence of 0.5 mM IBMX for 15 min in 0 µM Ca2+, and then challenged with 0, 1.2, or
10 µM free Ca2+ in the presence of 0.5 mM IBMX. At the end of a 40-min stimulation period, the
cells were treated with lysis buffer, and cell extracts were taken for
assay of cGMP. B, for assay of cAMP levels, the cells were
treated as for cGMP assay except that IBMX was not present in any
incubations and at the end of the stimulation period only the
supernatant was taken for assay of cAMP. The data are shown as
mean ± S.E. (n = 4).
|
|
Identification of Putative NCS-1-binding Proteins in Adrenal
Subcellular Fractions--
The persistent association of NCS-1 with
cellular membranes in the presence of Ca2+ chelators
suggests that NCS-1 may make Ca2+-independent interactions
with at least some of its target proteins. In order to examine this
possibility and to investigate the nature of NCS-1-binding proteins, we
established an assay based on the binding of biotinylated NCS-1 to
proteins separated by SDS-PAGE. In initial experiments, multiple
putative binding partners were detected using biotinylated NCS-1
overlays, and, therefore, to establish the specificity of this binding
it was compared with that with a distinct biotinylated protein of
similar molecular mass, the myristoylated GTP-binding protein ARF1,
also expressed as a recombinant protein (33). In these experiments, the
ARF1 was not activated by the addition of GTP and, therefore, was used simply as a control for nonspecific binding of a biotinylated probe.
From a comparison of overlays, a series of bands, particularly of less
than about 30 kDa, were detected by both probes in a microsome fraction
(Fig. 6A) and are, therefore,
nonspecific. NCS-1, however, detected a series of specific bands in the
absence or presence of Ca2+ (Fig. 6A,
left and center panels) not detected
by biotinylated ARF1 (Fig. 6A, right
panel) particularly in granule membrane and microsome
fractions. In addition, other bands were detected by biotinylated NCS-1
only in the presence of 10 µM Ca2+ in
cytosol, granule membrane, and microsome fractions (Fig.
6A), indicating the presence of specific
Ca2+-dependent as well as
Ca2+-independent NCS-1-binding proteins in adrenal
subcellular fractions. Similar results were found in three separate
experiments. We compared binding proteins detected in the absence or
presence of 10 µM Ca2+ by biotinylated NCS-1
and biotinylated calmodulin. As illustrated for binding to microsomes
in 10 µM Ca2+, some bands were detected by
both probes, but the two Ca2+-binding proteins also
specifically detected distinct proteins (Fig. 6B).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 6.
Identification of NCS-1-binding proteins in
adrenal subcellular fractions using biotinylated NCS-1 overlays.
Cytosol (Cyto), chromaffin granule membrane (G. memb), and microsome (Micro) fractions from adrenal
medulla were separated by SDS-PAGE on 10% gels and transferred to
nitrocellulose. A, left panel, binding
proteins detected with biotinylated NCS-1 in the absence of
Ca2+ with the positions of molecular mass standards shown
on the left. Center panel, binding
proteins detected with biotinylated NCS-1 in the presence of 10 µM Ca2+.
Ca2+-dependent binding proteins are indicated
on the right of each track. Right panel, proteins detected with biotinylated ARF1 in the
presence of 10 µM Ca2+, revealing a group of
nonspecifically detected bands. B, comparison of proteins
detected in the presence of 10 µM Ca2+ by
biotinylated calmodulin (CaM) and biotinylated NCS-1 in the
microsome fraction. Proteins specific for one or the other probe are
indicated with diamonds
(Ca2+-dependent binding) or closed circles (Ca2+-independent binding).
|
|
A well characterized calmodulin-binding protein is the 61-kDa subunit
of calcineurin (34). NCS-1 has been shown to activate calcineurin
in vitro (16), so we compared the Ca2+
dependence of binding of NCS-1 and calmodulin to purified calcineurin in the overlay assay. No binding was detected with the ARF1 control. With calmodulin, binding to calcineurin was completely
Ca2+-dependent (Fig.
7). In contrast, while binding of NCS-1
to calcineurin was increased at 10 µM Ca2+ it
was also detectable at 0 Ca2+. Calcineurin may account for
one of the polypeptides identified in adrenal fractions at about 60 kDa
that did not show marked Ca2+-dependence of NCS-1 binding
(Fig. 6).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 7.
Binding of biotinylated NCS-1 and calmodulin
to calcineurin. Using biotinylated protein overlays, the ability
of NCS-1, calmodulin, or ARF1 to bind to purified bovine brain
calcineurin (0.1 µg/track) in the absence or presence of 10 µM Ca2+ was compared. No binding was detected
with ARF1 or with calmodulin in the absence of Ca2+.
Binding to the 61-kDa subunit is shown.
|
|
 |
DISCUSSION |
The functional importance of frequenin and its orthologue NCS-1 in
the regulation of calcium-dependent exocytosis of synaptic vesicles and dense-core granules in vivo has been
established (9, 11, 14), but it is not clear whether overexpression of
frequenin/NCS-1 modifies some aspect of membrane excitability, Ca2+ homeostasis, or some other aspect of signal
transduction or if it has a direct effect on the exocytotic machinery.
For further examination of NCS-1 action and identification of its
specific biochemical targets, we have expressed and characterized
recombinant myristoylated NCS-1. Following co-expression with yeast
N-myristoyltransferase, about 50% of the NCS-1 became
myristoylated. This is a lower proportion than for other family members
(19, 21-23) but still considerably higher than for other expressed
myristoylated proteins such as the GTP-binding protein ARF (33), for example.
The bacterially expressed NCS-1 protein appeared to be active as a
Ca2+-binding protein based on changed migration on SDS-PAGE
in the presence of Ca2+ and Ca2+-induced
changes in tryptophan fluorescence. Previous work on NCS-1 has
demonstrated a change in tryptophan fluorescence, due to a
Ca2+-dependent conformational change, that
consisted of an increase in peak emission (30). In contrast, with
myristoylated NCS-1, we saw a more complex pattern of changes
consistent with two conformational changes of differing
Ca2+ sensitivity. Similar differences in the effect of
Ca2+ on tryptophan fluorescence for myristoylated
versus nonmyristoylated species have been reported for
recoverin (18). The initial increase in peak emission occurred over the
range of Ca2+ concentration from 0.1 to 1.0 µM, and this is consistent with previous work on direct
assay of Ca2+ binding to NCS-1. These data have shown
binding over this Ca2+ range due to two sites with high
cooperativity. NCS-1 contains three potential functional EF-hand
domains with an additional N-terminal domain lacking key residues
required for Ca2+ coordination (9). The changes in
tryptophan fluorescence we observed at higher Ca2+
concentrations may reflect Ca2+ binding to a third low
affinity site not detected by direct Ca2+ binding. Further
interpretation of the Ca2+-induced changes in tryptophan
fluorescence will require information on structural change during
Ca2+-binding. Nevertheless, these data confirm that the
recombinant myristoylated NCS-1 is a functional
Ca2+-binding protein.
An effect of overexpression of a protein on neurotransmission in
vivo as seen for frequenin (9) could be due to effects on many
different aspects of presynaptic function. We have previously demonstrated that overexpression of NCS-1 in PC12 cells resulted in an
increase in the extent of dense core granule exocytosis evoked by ATP
acting on a purinergic receptor (14), indicating that the effect of
frequenin/NCS-1 was not limited to synaptic vesicle exocytosis. These
data also show that NCS-1 is not normally present in limiting amounts
in intact PC12 cells, since increased levels of expression can exert a
stimulatory effect. In contrast, when the overexpressing PC12 cells
were permeabilized prior to stimulation by calcium, no effect of NCS-1
overexpression on exocytosis was detected. These findings may be
consistent with NCS-1 acting on some early step in stimulus-secretion
coupling in intact cells that would be bypassed in permeabilized cells.
Alternatively, the possibility could not be ruled out that
permeabilization resulted in loss of soluble NCS-1, explaining the
difference in results between intact and permeabilized cells. We set
out, therefore, to test these possibilities by directly manipulating
cellular NCS-1 levels after permeabilization.
Digitonin-permeabilized adrenal chromaffin cells have been shown to be
a useful model to examine the effects of exogenous soluble proteins on
Ca2+-dependent exocytosis, allowing
demonstration of the stimulatory effects of annexin II (35), 14-3-3 proteins (32),
-SNAP (36), calmodulin (37), and
cAMP-dependent protein kinase (38). Following digitonin
permeabilization, about 50% of endogenous NCS-1 leaked from the cells.
Preincubation with exogenous NCS-1 resulted in a 3-fold increase in
cell-associated NCS-1, demonstrating its ability to enter the cells and
remain cell-associated through all of the steps of the exocytosis
assay. This association was Ca2+-independent, consistent
with the ability of NCS-1 to bind to membranes in a
Ca2+-independent manner. Using protocols similar to those
used successfully with other proteins, we did not see any stimulatory
effect of exogenous NCS-1 on exocytosis at low or high Ca2+
concentrations. These results are unlikely to be due to the levels of
NCS-1 remaining following permeabilization already being sufficient, since intact cell studies with overexpression clearly show that NCS-1
levels are not saturating in neurons or PC12 cells (9, 11, 14). These
data in combination with previous work on cells permeabilized after
transfection (14) argue that NCS-1 does not directly regulate the
machinery for Ca2+-triggered exocytosis but may act on
signal transduction pathways that control exocytosis or an early step
in stimulus-secretion coupling.
Frequenin has been shown to stimulate membrane-bound photoreceptor
guanylate cyclase at low but not high Ca2+ concentrations
in rod outer segment membranes (9). It is not known if it can stimulate
the forms of guanylate cyclase expressed in neuronal or other cell
types. We did not detect any changes in cGMP levels following
introduction of NCS-1 into permeabilized chromaffin cells. Similarly,
while NCS-1 (16) and the related protein VILIP (38) have been suggested
to be potential regulators of cAMP, we did not see any effects on cAMP
levels. We had examined these cyclic nucleotides, since both have been
shown to modulate dense core granule exocytosis in chromaffin cells
(39). It seems unlikely, therefore, that cyclic nucleotide generation
is part of the pathway by which NCS-1 overexpression enhances dense
core granule exocytosis.
Related members of this family of Ca2+-binding proteins
have been reported to only bind to membranes in the presence of
Ca2+ (19, 21, 22, 23, 24), consistent with the
Ca2+/myristoyl switch model for recoverin (3). In contrast,
one member of the neuronal calcium sensor family, guanyl
cyclase-activating protein 2, has been shown to have a reversed
Ca2+ dependence in that it binds membranes at low
Ca2+ and dissociates as Ca2+ is elevated (24).
NCS-1 behaves in a manner distinct from these proteins in that the
myristoylated protein shows Ca2+-independent membrane
binding. It is significant that endogenous NCS-1 remains
membrane-associated in adrenal medullary fractions (14) and with rat
brain membranes, even following extensive washing in the presence of
Ca2+ chelators and even with carbonate buffer to extract
extrinsic membrane proteins demonstrating a tight
Ca2+-independent membrane interaction. Recent work has
shown that the binding of the related protein S-modulin to membranes,
which is Ca2+-dependent, requires the presence
of a series of charged residues at the C terminus (40). These charged
residues are absent in NCS-1, suggesting a distinct mechanism for
membrane interaction. These findings demonstrate, therefore, that NCS-1
makes Ca2+-independent interactions with target membrane
and that Ca2+ does not regulate its membrane association.
Presumably, conformational change following Ca2+ binding in
membrane-bound NCS-1 will lead to activation of target membrane
proteins. This situation is distinct from the
Ca2+/myristoyl switch model based on the properties of recoverin.
Little information was available on the nature and number of possible
target proteins for NCS-1 or other members of this family of
Ca2+-binding proteins or on whether their binding proteins
are distinct from or overlap with those for calmodulin. The use of
biotinylated NCS-1 has now allowed the detection of several binding
proteins in subcellular fractions of adrenal medulla, some of which
showed Ca2+-independent and others
Ca2+-dependent interactions. These were shown
to be specific based on lack of detection by biotinylated ARF1. In
addition, a distinct pattern of Ca2+-dependent
binding partners was detected using biotinylated calmodulin. The
multitude of binding partners detected is consistent with the various
biochemical effects of NCS-1/frequenin that have been reported. It has
been suggested that NCS-1 overlaps with calmodulin in its target
protein interactions (16), but our data on biotinylated NCS-1 binding
suggest that NCS-1 is unlikely to act simply as a calmodulin
replacement but also has specific target proteins distinct from those
for calmodulin. In the case of one common target protein, calcineurin,
binding of calmodulin was strictly Ca2+-dependent, but binding of NCS-1 was not
entirely Ca2+-dependent. These data suggest,
therefore, a distinct mode of action for NCS-1 in which it is
constitutively associated with membranes and certain target proteins at
resting Ca2+ concentration, allowing it to act as a rapid
transducer of Ca2+ signals in response to localized changes
in Ca2+ concentration.
 |
ACKNOWLEDGEMENTS |
We thank Geoff Williams for technical
assistance and the preparation of chromaffin cell cultures and Dr.
J. I. Gordon (Washington University School of Medicine, St. Louis,
Missouri) for the pBB131 plasmid encoding yeast
N-myristoyltransferase. We thank Dr. Andrea Varro for
assistance and guidance with HPLC analyses.
 |
Note Added in Proof |
It has recently been shown that the yeast
homologue of frequenin/NCS-1 activates phosphatidylinositol-4-OH kinase
and binds to the enzyme in a Ca2+-independent manner (41).
 |
FOOTNOTES |
*
This work was supported by grants from the Medical Research
Council and the Wellcome Trust.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom all correspondence should be addressed. Tel.:
44-151-794-5305; Fax: 44-151-794-5337; E-mail:
burgoyne@liv.ac.uk.
 |
ABBREVIATIONS |
The abbreviations used are:
NCS-1, neuronal
Ca2+ sensor 1;
ARF, ADP-ribosylation factor;
NMT, N-myristoyltransferase;
HPLC, high pressure liquid
chromatography;
PIPES, 1,4-piperazinediethanesulfonic acid;
PAGE, polyacrylamide gel electrophoresis;
IBMX, isobutylmethylxanthine.
 |
REFERENCES |
| 1.
|
Braunewell, K.-H.,
and Gundelfinger, E. D.
(1998)
Cell Tissue Res.
295,
1-12
|
| 2.
|
Dizhoor, A. M.,
Ray, S.,
Kumar, S.,
Niemi, G.,
Spencer, M.,
Brolley, D.,
Walsh, K. A.,
Philipov, P. P.,
Hurley, J. B.,
and Stryer, L.
(1991)
Science
251,
915-918[Abstract/Free Full Text]
|
| 3.
|
Ames, J. B.,
Ishima, R.,
Tanaka, T.,
Gordon, J. I.,
Stryer, L.,
and Ikura, M.
(1997)
Nature
389,
198-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Chen, C.-K.,
Inglese, J.,
Lefkowitz, R. J.,
and Hurley, J. B.
(1995)
J. Biol. Chem.
270,
18060-18066[Abstract/Free Full Text]
|
| 5.
|
Klenshin, V. A.,
Calvert, P. D.,
and Bownds, M. D.
(1995)
J. Biol. Chem.
270,
16147-16152[Abstract/Free Full Text]
|
| 6.
|
Lenz, S. E.,
Henschel, Y.,
Zopf, D.,
Voss, B.,
and Gundelfinger, E. D.
(1992)
Mol. Brain Res.
15,
133-140[Medline]
[Order article via Infotrieve]
|
| 7.
|
Okazaki, K.,
Watanabe, M.,
Ando, Y.,
Hagiwara, M.,
Terasawa, M.,
and Hidaka, H.
(1992)
Biochem. Biophys. Res. Commun.
185,
147-153[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Kobayashi, M.,
Takamatsu, K.,
Saitoh, S.,
Miura, M.,
and Noguchi, T.
(1992)
Biochem. Biophys. Res. Commun.
189,
511-517[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Pongs, O.,
Lindemeier, J.,
Zhu, X. R.,
Theil, T.,
Endelkamp, D.,
Krah-Jentgens, I.,
Lambrecht, H.-G.,
Koch, K. W.,
Schwemer, J.,
Rivosecchi, R.,
Mallart, A.,
Galceran, J.,
Canal, I.,
Barbas, J. A.,
and Ferrus, A.
(1993)
Neuron
11,
15-28[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Nef, S.,
Fiumelli, H.,
de Castro, E.,
Raes, M.-B.,
and Nef, P.
(1995)
J. Recept. Signal Trans.
15,
365-378
|
| 11.
|
Olafsson, P.,
Wang, T.,
and Lu, B.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8001-8005[Abstract/Free Full Text]
|
| 12.
|
Olafsson, P.,
Soares, H. D.,
Herzog, K.-H.,
Wang, T.,
Morgan, J. I.,
and Lu, B.
(1997)
Mol. Brain Res.
44,
73-82[Medline]
[Order article via Infotrieve]
|
| 13.
|
De Castro, E.,
Nef, S.,
Fiumelli, H.,
Lenz, S. E.,
Kawamura, S.,
and Nef, P.
(1995)
Biochem. Biophys. Res. Commun.
216,
133-140[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
McFerran, B. W.,
Graham, M. E.,
and Burgoyne, R. D.
(1998)
J. Biol. Chem.
273,
22768-22772[Abstract/Free Full Text]
|
| 15.
|
Poulain, C.,
Ferrus, A.,
and Mallart, A.
(1994)
Pflugers Arch.
427,
71-79[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Schaad, N. C.,
De Castro, E.,
Nef, S.,
Hegi, S.,
Hinrichsen, R.,
Martone, M. E.,
Ellisman, M. H.,
Sikkink, R.,
Sygush, J.,
and Nef, P.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
9253-9258[Abstract/Free Full Text]
|
| 17.
|
Rivosecchi, R.,
Pongs, O.,
Theil, T.,
and Mallart, A.
(1994)
J. Physiol.
474,
223-232[Abstract/Free Full Text]
|
| 18.
|
Ray, S.,
Zozulya, S.,
Niemi, G. A.,
Flaherty, K. M.,
Brolley, D.,
Dizhoor, A. M.,
Mckay, D. B.,
Hurley, J. B.,
and Stryer, L.
(1992)
Proc. Natl. Acad. Sci U. S. A.
89,
5705-5709[Abstract/Free Full Text]
|
| 19.
|
Zozulya, S.,
and Stryer, L.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
11569-11573[Abstract/Free Full Text]
|
| 20.
|
Towler, D. A.,
Gordin, J. I.,
Adams, S. P.,
and Glaser, L.
(1988)
Annu. Rev. Biochem.
57,
69-99[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Ladant, D.
(1995)
J. Biol. Chem.
270,
3179-3185[Abstract/Free Full Text]
|
| 22.
|
Faurobert, E.,
Chen, C.-K.,
Hurley, J. B.,
and Teng, D. H.-F.
(1996)
J. Biol. Chem.
271,
10256-10262[Abstract/Free Full Text]
|
| 23.
|
Kobayashi, M.,
Takamatsu, K.,
Saitoh, S.,
and Noguchi, T.
(1993)
J. Biol. Chem.
268,
18898-18904[Abstract/Free Full Text]
|
| 24.
|
Oleshevskaya, E. V.,
Hughes, E. E.,
Hurley, J. B.,
and Dizhoor, A. M.
(1997)
J. Biol. Chem.
272,
14327-14333[Abstract/Free Full Text]
|
| 25.
|
Duronio, R. J.,
Jackson-Machelski, E.,
Heuckroth, R. O.,
Olins, P. O.,
Devine, C. S.,
Yonemoto, W.,
Slice, L. W.,
Taylor, S. S.,
and Gordon, J. I.
(1990)
Proc, Natl. Acad. Sci. U. S. A.
87,
1506-1510[Abstract/Free Full Text]
|
| 26.
|
Zozulya, S.,
Ladant, D.,
and Stryer, L.
(1995)
Methods Enzymol.
250,
383-393[Medline]
[Order article via Infotrieve]
|
| 27.
|
Burgoyne, R. D.
(1992)
in
Neuromethods
(Boulton, A.
, Baker, G.
, and Taylor, C., eds), Vol. 20
, pp. 433-470, Humana Press Inc., Totowa, NJ
|
| 28.
|
Von Euler, U. S.,
and Floding, I.
(1955)
Acta Physiol. Scand.
118,
45-56
|
| 29.
|
Burgoyne, R. D.,
and Williams, G.
(1997)
FEBS Lett.
414,
349-352[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Cox, J. A.,
Drussel, I.,
Comte, M.,
Nef, S.,
Nef, P.,
Lenz, S. E.,
and Gundelfinger, E. D.
(1994)
J. Biol. Chem.
269,
32807-32814[Abstract/Free Full Text]
|
| 31.
|
Burgoyne, R. D.,
and Morgan, A.
(1993)
Biochem. J.
293,
305-316
|
| 32.
|
Morgan, A.,
and Burgoyne, R. D.
(1992)
Nature
355,
833-835[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Glenn, D. E.,
Thomas, G. M. H.,
O'Sullivan, A. J.,
and Burgoyne, R. D.
(1998)
J. Neurochem.
71,
2023-2033[Medline]
[Order article via Infotrieve]
|
| 34.
|
Billingsley, M. L.,
Pennypacker, K. R.,
Hoover, C. G.,
Brigati, D. J.,
and Kincaid, R. L.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
7585-7589[Abstract/Free Full Text]
|
| 35.
|
Ali, S. M.,
Geisow, M. J.,
and Burgoyne, R. D.
(1989)
Nature
340,
313-315[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Morgan, A.,
and Burgoyne, R. D.
(1995)
EMBO J.
14,
232-239[Medline]
[Order article via Infotrieve]
|
| 37.
|
Chamberlain, L. H.,
Roth, D.,
Morgan, A.,
and Burgoyne, R. D.
(1995)
J. Cell Biol.
130,
1063-1071[Abstract/Free Full Text]
|
| 38.
|
Braunewell, K.-H.,
Spilker, C.,
Behnisch, T.,
and Gundelfinger, E. D.
(1997)
J. Neurochem.
68,
2129-2139[Medline]
[Order article via Infotrieve]
|
| 39.
|
Morgan, A.,
Wilkinson, M.,
and Burgoyne, R. D.
(1993)
EMBO J.
12,
3747-3752[Medline]
[Order article via Infotrieve]
|
| 40.
|
Matsuda, S.,
Hisatoni, O.,
and Tokunaga, F.
(1999)
Biochemistry
38,
1310-1315[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Hendricks, K. B.,
Wang, B. Q.,
Schnieders, E. A.,
and Thorner, J.
(1999)
Nat. Cell Biol
1,
234-241[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. P. Yamniuk, H. Ishida, and H. J. Vogel
The Interaction between Calcium- and Integrin-binding Protein 1 and the {alpha}IIb Integrin Cytoplasmic Domain Involves a Novel C-terminal Displacement Mechanism
J. Biol. Chem.,
September 8, 2006;
281(36):
26455 - 26464.
[Abstract]
[Full Text]
[PDF]
|
 |
|